Search Results
62 items found for "Thomas S Hoang"
- The GPCR-Gαs-PKA signaling axis promotes T cell dysfunction and cancer immunotherapy failure
The Author(s), under exclusive licence to Springer Nature America, Inc." Authors Victoria H Wu , Bryan S Yung , Farhoud Faraji , Robert Saddawi-Konefka , Zhiyong Wang , Alexander T Wenzel , Miranda J Song , Meghana S Pagadala , Lauren M Clubb , Joshua Chiou , Sanju Sinha , Marin Matic , Francesco Raimondi , Thomas S Hoang , Rebecca Berdeaux , Dario A A Vignali , Ramiro Iglesias-Bartolome
- Ep 50 with Dr. Thomas P. Sakmar
Thomas P. Sakmar About Dr. Thomas P. dynamics simulations and coarse-grain sampling approaches for membrane proteins in collaborations with Thomas Thomas P.
- Ep 119 with Tanishka S. Saraf
GPCR Podcast << Back to podcast list Tanishka S. Saraf About Tanishka S. neurobiology of neuropsychiatric disorders and to develop safe and effective treatments. " Tanishka S.
- Ep 38 with Dr. Alexander S. Hauser
Alexander S. Hauser About Dr. Alexander S. Alexander S.
- Developing a PROTAC to Degrade the Constitutively Active Onco-GPCR in Uveal Melanoma
Thomas Sakmar’s laboratory at Rockefeller University, where she studies the signaling and degradation started her Ph.D. at the Tri-Institutional Ph.D. program in Chemical Biology, where she joined the lab of Thomas
- Ep 66 with Dr. Antony A. Boucard Jr
Thomas Südhof . Boucard´s lab focuses on molecular and cellular mechanisms underlying the function of adhesion GPCRs
- GPCR Retreat 2023 - Part II
Thomas Sakmar’s laboratory at The Rockefeller University, where she study’s the signaling and degradation started her Ph.D. at the Tri-Institutional Ph.D. program in Chemical Biology, where she joined the lab of Thomas
- Using food perception and bioamine signaling networks to slow aging
Miller 1, Shijiao Huang 1, Elizabeth S. Dean 1, and Scott F. Leiser 1 1.
- Ep 56 with Dr. Adriano Marchese
He then moved to Thomas Jefferson University in Philadelphia, PA, for his postdoctoral training in Jeff
- Increased protease-activated receptor 1 autoantibodies are associated with severe COVID-19
Schinke , Nadja Käding , Jens Y Humrich , Otávio Cabral-Marques , Joana P Bernardes , Neha Mishra , Thomas
- Ep 18 with Dr. Yamina Berchiche
Oprea , Thomas Sakmar , Aurelien Rizk & Yaroslav Nikolaev .
- Respiratory infections predominate after day 100 following B-cell maturation antigen-directed CAR T-cell therapy
Authors Jessica S Little , Megha Tandon , Joseph Seungpyo Hong , Omar Nadeem , Adam S Sperling , Noopur
- Ep 42 with Dr. Randy Hall
to the Vollum Institute in Portland, Oregon, to do a post-doctoral fellowship in the laboratory of Thomas
- Ep 107 with Dr. Roger Sunahara
G protein splice forms, specifically the short and long forms of the stimulatory G protein, Galpha-s( s) and Galpha-s(l), respectively. We demonstrated that Galpha-s(l), but not Galpha-s(s), regulates extracellularly regulated kinases (ERK We speculate that these aberrations in Galpha-s(l), specifically, may be involved in other pathologies
- Deciphering the genetic landscape of lumpy skin disease: Unraveling variable virulence through comprehensive genome sequence analysis in India
Authors R Mishra, S K Biswas, S Nandi, S Mahajan, K G Sai Balaji, V Gairola, D Poloju, S Gulzar, K P
- Bispecific antibodies targeting BCMA or GPRC5D are highly effective in relapsed myeloma after CAR T-cell therapy
Barbara Jeker, Michele Hoffmann, Nicolaus Kröger, Bastian von Tresckow, Carlos Fernández de Larrea, Thomas
- Blockade of vasoactive intestinal peptide receptor 2 (VIPR2) signaling suppresses cyclin D1-dependent cell-cycle progression in MCF-7 cells
The percentage of cells in the S-M phase was decreased in MCF-7 cells treated with KS-133. MEK) inhibitor U0126 and the class I PI3K inhibitor ZSTK474 decreased the percentage of cells in the S KS-133 reduced the percentage of cells in the S phase more than treatment with U0126 or ZSTK474 alone regulates cyclin D1 levels through the cAMP/PKA/ERK and PI3K/AKT/GSK3β pathways, and mediates the G1/S
- CircFKBP5 Suppresses Apoptosis and Inflammation and Promotes Osteogenic Differentiation
differentiation of hDPSCs was investigated by performing alkaline phosphatase (ALP) staining and alizarin red S Authors Cuiwei Liang , Wenmiao Li , Qian Huang , Qitao Wen .
- Stimulation of ectopically expressed muscarinic receptors induces IFN-γ but suppresses IL-2 production by inhibiting activation of pAKT pathways in primary T cells
Authors Trang T T Nguyen , Wen Lu , Wandi S Zhu , K Mark Ansel , Hong-Erh Liang , Arthur Weiss .
- Phase 1/2 study of sorafenib added to cladribine, high-dose cytarabine, G-CSF, and mitoxantrone in untreated AML
Othus , Kelsey-Leigh A Garcia , Mary-Elizabeth M Percival , Ryan D Cassaday , Vivian G Oehler , Pamela S Becker , Jacob S Appelbaum , Janis L Abkowitz , Johnnie J Orozco , Siobán B Keel , Paul C Hendrie , Bart
- Ep 132 with Dr. Richard Premont
Harrington Discovery Institute and Case Western Reserve University, where he studies GPCR regulation by S-nitrosylation by GIT/PIX scaffolding complexes during cellular signaling, and characterizing the role of protein S-nitrosylation
- Ep 130 with Dr. Richard Premont
Harrington Discovery Institute and Case Western Reserve University, where he studies GPCR regulation by S-nitrosylation by GIT/PIX scaffolding complexes during cellular signaling, and characterizing the role of protein S-nitrosylation
- Ep 133 with Dr. Richard Premont
Harrington Discovery Institute and Case Western Reserve University, where he studies GPCR regulation by S-nitrosylation by GIT/PIX scaffolding complexes during cellular signaling, and characterizing the role of protein S-nitrosylation
- Ep 131 with Dr. Richard Premont
Harrington Discovery Institute and Case Western Reserve University, where he studies GPCR regulation by S-nitrosylation by GIT/PIX scaffolding complexes during cellular signaling, and characterizing the role of protein S-nitrosylation
- Ep 09 with Lauren Celano
GPCR podcast episode, we sat down to chat with Lauren Celano to talk about career options for Ph.D.’s.
- Spliceosome mutations are associated with clinical response in a phase 1b/2 study of the PLK1 inhibitor onvansertib in combination with decitabine in relapsed or refractory acute myeloid leukemia
Authors Peter J P Croucher , Maya Ridinger , Pamela S Becker , Tara L Lin , Sandra L Silberman , Eunice S Wang , Amer M Zeidan Tags AML , Biomarker , Hypomethylating agents , Onvansertib , PLK1 , Splicing
- Terms and Conditions | Dr. GPCR Ecosystem
Access and Use of the Services: Customer(s) is/are required to register with Ecosystem.DrGPCR.com and If Customer(s) choose(s) to register for the Services, he/she/they agree(s) to provide and maintain true agree(s) to be bound by the terms of this ATS and to provide Ecosystem.DrGPCR.com with all the information Service(s)’ payment for the membership fee shall be made in full, via Wix Payment. All accrued rights to membership fee payment(s) and the terms of Section 4 hereinabove shall survive
- GPR68-ATF4 signaling is a novel prosurvival pathway in glioblastoma activated by acidic extracellular microenvironment
Authors Charles H Williams , Leif R Neitzel , Jessica Cornell , Samantha Rea , Ian Mills , Maya S Silver Jovanni D Ahmad , Konstantin G Birukov , Anna Birukova , Henry Brem , Betty Tyler , Eli E Bar , Charles C Hong